Analysis of risk factors: The rationale of the guidelines of the Czech Hematological Society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia

Abstract

myeloproliferative disease, essential thrombocythemia, polycythemia vera, idiopathic myelofibrosis, risk factors, thrombosis, treatment algorithm